Ad copy

My dermatologist handed me the referral form before I'd finished my sentence. "You're past the point where freeze sessions are enough," she said. "We need to escalate." I'd been in her office for six minutes. She hadn't looked at my arms once. Dr. Pearson's voicemail came on a Wednesday afternoon. "Carol, this is Dr. Pearson's office. Due to her relocation to Portland, her practice will be closing effective October 15th. Your records will be transferred to Dr. James Whitfield. We'll be in touch to schedule your transition appointment." I listened to it twice. Seven years. I'd been seeing Dr. Pearson for seven years. She knew my hands. She'd watched them. Every new patch documented, photographed, frozen. She knew my mother's history — arms that had looked like bark by 65, quarterly appointments that became the rhythm of her life until they weren't enough anymore. Dr. Pearson had always been steady with me. "We're staying on top of it, Carol. We catch every new one before it has time to settle." Now she was in Portland. My first appointment with Dr. Whitfield was October 28th. I sat in the waiting room. New office. Same magazines about sun safety and dermatology. Different everything else. Dr. Whitfield walked in. Mid-40s. Efficient. Reading my chart before he'd fully entered the room. "Ms. Patterson." He sat. Pulled up the screen. "I've been going through your history with Dr. Pearson." He turned the monitor toward me. "2017: two patches, back of left hand. 2018: five patches spreading to right hand and wrist. 2019: forearms. 2020: upper arms. 2021 through 2024: between ten and fifteen active sites, new patches appearing every cycle in skin that was clear the visit before." He looked at me over his glasses. "Seven years of freeze sessions. Your actinic keratosis has progressed every year you've been under Dr. Pearson's care." "We had a system. She'd freeze every new one. I used the diclofenac between—" "A system that produced fifteen active sites." His voice was flat. "Ms. Patterson, your previous dermatologist was managing visible lesions. Nobody was addressing the field. That changes today." My stomach went cold. "What does that mean exactly?" "Field therapy. 5-fluorouracil cream, twice daily, six-week course. Then photodynamic therapy — two sessions minimum, possibly three. And I want to start imiquimod on the hand sites immediately. Three times a week going forward." He was already in the system. "If we don't see field response after the first round, we look at more aggressive options." "Seven years of freeze sessions and they never—" "That's why we're moving to field therapy. Spot treatment is over. This is whole-field intervention." "But new patches kept forming between freeze appointments. Every single—" "Because the subclinical field was never being addressed. We were chasing visible lesions while the field generating them was left untouched. We need to treat the entire affected area now." The printer started. He slid the treatment plan across the desk. 5-fluorouracil cream, six-week course: $320. Photodynamic therapy, three sessions: $2,400. Imiquimod cream, ongoing: $160/month. Freeze sessions quarterly: $175 each. Follow-up every 10 weeks: $190. $2,720 upfront. Then over $1,000 every quarter. Indefinitely. He stood. Checked his watch. The appointment was done. Seven minutes. I sat holding the treatment plan. My hands in my lap. Non-compliant. Outside in the parking structure, I called my sister. "How was the new one?" "He says Dr. Pearson's approach wasn't aggressive enough. Wants me on a cream twice a day for six weeks that makes your skin weep and crust. Then light therapy. $2,720 today. More than $1,000 every quarter after that." A pause. "Every quarter forever?" "He said if I don't proceed, he documents it as patient non-compliance." "But you've had freeze sessions every few months for seven years—" "And my patches got worse every year." "So more aggressive chemicals are the answer?" I didn't know what to say. That night I lay in bed with the ceiling and my thoughts. Dr. Pearson had done what Dr. Whitfield was proposing. Just less intensely. Freeze the visible patch. Diclofenac between sessions. Watch. Document. Schedule again. Fourteen freeze sessions. Thousands of dollars. Patches spreading every single year. Dr. Whitfield's plan was the same — amplified. More aggressive chemicals. Wider field treatment. Higher cost. Was more of the same going to fix what the same hadn't fixed in seven years? Or was I about to spend another $4,200 a year watching a field that neither protocol was ever actually reaching? At 2:30 AM I got up. Kitchen table. Laptop open. *why do AK patches keep forming after freeze sessions* *does liquid nitrogen treat subclinical field* *why does diclofenac stop working for actinic keratosis* The dermatology industry said the same thing in every article. Freeze sessions are first-line treatment for visible AK lesions. Monitor. Return when new patches appear. Then I found the patient communities. "Seven years of freeze sessions every three months. My patches are worse than when I started. My dermatologist just schedules the next one. Nobody asks why they keep coming back." "$175 a session, four times a year, for seven years. $4,900 in freeze sessions. My hands look worse now than they did when I started. But apparently the answer is to keep going." "The 5-FU was brutal. Six weeks of weeping, crusting skin. Couldn't wash dishes. Couldn't be in sunlight. Three months later — new patches at the edges of the treated area. They want to do another round." "Eight years. Eleven thousand dollars on sessions and specialist visits. New dermatologist says I need photodynamic therapy. If the freezing was ever going to work, shouldn't it have worked by now?" My hands went cold reading those. These women were me. Seven years behind them or seven years ahead of them, I couldn't tell anymore. I typed: *why does actinic keratosis keep spreading even with regular treatment* And my mother's hands came into my mind. She'd been on the quarterly freeze schedule for nine years. Same appointment every three months. Same chair. Same liquid nitrogen. Same "that one looks better" at the start of every session, followed by "and here are four new ones forming." Nine years. More than $7,000. Her AK never stopped moving. The appointments defined her calendar. She stopped wearing the blouses she loved — the short sleeves, the lighter fabrics — because the patches on her arms made every outing feel like a liability. She gave up her summer book club because the afternoon sun through the library windows made her self-conscious about reaching across the table. She stopped accepting invitations that involved being outdoors in warm weather. She arranged her whole life around a condition that kept spreading anyway. Then the 5-fluorouracil. Six weeks of raw, crusting skin. Back again by summer. Imiquimod next. Insurance rejections. Full recurrence. I visited her one afternoon a few years before she passed. She pulled her sleeve down over her wrist the moment I walked in. Reflex. She didn't even notice she'd done it. "Nine years," she said, quietly. "Nine years on the schedule. Three rounds of field therapy. Every treatment they had. And I couldn't stop it." She died at 74. Not from her AK. But she never wore short sleeves again. Never stopped reaching for her sleeve when someone's eyes moved toward her arms. Never got her summer back. I closed the laptop. Sat in the dark kitchen. Fourteen freeze sessions over seven years. Patches spreading the entire time. And Dr. Whitfield's answer was to do it harder. Wider. More expensively. The same logic my mother's doctors had used for nine years before everything failed. The treatment plan was on the kitchen counter. $2,720 today. $1,000 every quarter. Indefinitely. I left it there. Two weeks went by. Dr. Whitfield's office called. "Ms. Patterson, you haven't scheduled your photodynamic therapy. Dr. Whitfield needs to confirm your treatment intentions." "I'm still deciding." "Ms. Patterson, this is a progressive condition. Every week without field treatment allows the subclinical damage to deepen. Dr. Whitfield was very specific about the urgency—" "I understand. I'm still deciding." I hung up before she could finish. My daughter came for dinner on a Sunday. Found me in the backyard, just standing at the edge of the garden. "Mom. What's going on." "Thinking." "About?" "Fourteen freeze sessions. Seven years. Why they never stopped anything." "The new dermatologist said you need to go more aggressive—" "More aggressive. Same approach, higher cost, stronger chemicals. The exact same thing that didn't work for seven years, done harder." She sat down next to me. "But what if he's right? What if it keeps spreading? What if you end up like Grandma?" "What if I spend $4,200 a year for the next seven years on field therapy that wears off in two months? What if I do every round he's recommending and I'm still sitting in that chair watching new patches form? What if I follow Grandma's path exactly — nine years of freeze sessions, then field therapy, then more field therapy, then full recurrence, and I never get my summers back either?" She was quiet. That week I went deep. Research papers. Dermatology journals. Clinical studies on field treatment outcomes. And I found the answer to the question that had been there since Dr. Whitfield's appointment. *Why doesn't freezing stop new patches from forming?* Liquid nitrogen destroys the individual lesion. The visible patch. The one the dermatologist can see and reach. That's why the site calms after a session. That's why it looks better at the follow-up. But the subclinical field — the wide zone of UV-damaged keratinocytes spreading through the surrounding dermis, invisible on the surface — doesn't get touched. Liquid nitrogen is a targeted tool. A point treatment. It was never designed to address a field. The cells in that subclinical zone keep dividing. Keep signaling. Keep generating. Within weeks, a new lesion surfaces in skin that looked perfectly clear at the last appointment. Then another. Then another. Same schedule, every quarter. That's the freeze-and-return cycle. Not because the freezing is maintaining anything. Because the field underneath keeps generating, on schedule, every time. And the diclofenac? It reduces visible inflammation. Softens the surface. But it's water-based. It sits on the stratum corneum, the outermost barrier, and penetrates at less than four percent into the dermis. The keratinocytes generating new lesions live deeper. Where water-based compounds don't go. Like trying to cool a fire in the foundation by pouring water on the porch. And the 5-fluorouracil Dr. Whitfield wanted? It attacks the surface field aggressively. Your skin weeps and crusts for weeks as visible damaged cells are destroyed. But the dermis underneath — where the UV-damaged keratinocytes that generate the next round of lesions actually live — isn't reached. Nothing in the standard protocol is designed to reach it. I stared at the screen. Fourteen freeze sessions that destroyed visible patches while the generating field ran underneath. Seven years of diclofenac sitting on the surface. Field chemotherapy next — treating a wider zone of surface while the dermis kept generating below. The same logic. Harder. At fifteen times the annual cost. Then I found the research I hadn't been looking for. Studies on lipid-soluble botanical delivery and UV-damaged keratinocyte populations. The finding: water-based compounds cannot cross the stratum corneum to reach the dermis where the subclinical field lives. But cold-pressed plant oils can. Specifically camellia oil and sea buckthorn oil — lipid carriers that penetrate all seven skin layers and deliver actives directly to the dermal layer. To the field. Oil-soluble vitamin C — ascorbyl tetraisopalmitate — at clinical concentration: inhibits the UV-induced oxidative cascade driving abnormal keratinocyte proliferation. Not at the surface. In the dermis. Where the field lives and generates. Bakuchiol at clinical concentration: supports normal keratinocyte cycling. Replaces the abnormal proliferation pattern with healthy cell renewal from the dermal layer outward. The principle: oil-soluble actives require a lipid carrier. Water cannot transport them through the skin barrier. Cold-pressed camellia and sea buckthorn oil penetrate the stratum corneum and carry the actives with them. All the way down. All the way to the field. So I started testing botanical oils. First: the top-rated vitamin C body oil on Amazon. Thousands of reviews. Applied every morning without missing one for five weeks. Patches still rough. Edges still raised. Next: the botanical formula from the integrative health clinic. The one two people had recommended. Six weeks, twice daily. Maybe slightly less textured. Maybe. I wasn't sure enough to trust it. Third: a premium formulation from a specialty skincare brand. The most expensive option I could find. Nothing. New patch forming at the edge of the treated zone. My appointment was in three weeks. I was going to have to schedule the field therapy. $2,720 upfront. $1,000 every quarter. Starting over on a protocol that had already failed my mother nine times. One week before the appointment, I was at the Saturday farmers market in town. Found myself at a skincare vendor's table. Looking at botanical oils. Nice packaging. Clean labels. Nothing I hadn't already tried. A woman was standing at the same table. Late 60s. Reading the ingredient list on a bottle with the kind of focus that meant she already knew what she was looking for. "Don't bother," she said without looking up. "Sorry?" "The carrier oils." She turned the bottle over. "Sunflower. Safflower. They moisturize. They don't penetrate." "I've been through three brands. None of them touched my patches." She set the bottle down and looked at me properly. "Actinic keratosis?" "Fifteen active sites. Hands, forearms, upper arms. Seven years on the freeze schedule that never stopped the field from spreading. New dermatologist wants to move me to field chemotherapy and photodynamic therapy. Over $1,000 every quarter." She nodded. "My sister. Exactly the same. Years of freeze sessions. Then a year of botanical oils that did nothing. Almost started the aggressive protocol." "What stopped her?" "I did. I started researching why the oils weren't working." She picked up a different bottle from the display. "It's the carrier. Sunflower and safflower sit on the surface. They don't reach the dermis. You need cold-pressed camellia oil and sea buckthorn oil — the two lipid carriers that actually transport actives through all seven skin layers. And the vitamin C has to be oil-soluble. Ascorbyl tetraisopalmitate. Not ascorbic acid — water-soluble, bounces off the stratum corneum. The oil-soluble form at clinical concentration, in a camellia and sea buckthorn carrier, with bakuchiol for cellular turnover. And zero water in the formula. Water dilutes penetration. Every drop cuts what reaches the dermis." She took out her phone. "There's one formula that actually does it right. Dermiqua. Cold-pressed camellia and sea buckthorn as the carrier. Oil-soluble vitamin C at clinical concentration. Bakuchiol. Sixteen botanicals. Zero water. Zero filler. It reaches the dermis. The field." She showed me the ingredient list. It matched the research I'd found exactly. Ninety-day money-back guarantee. "My sister has been using it for five months. Hands clear — texture gone, edges flat, no new patches at her last two check-ins. No field chemotherapy. No photodynamic therapy. After seven years of freeze sessions that never stopped anything." "Her dermatologist was okay with this?" "Watched it for two visits. If the results hold — and they're holding — annual monitoring only. No more quarterly sessions." "It's been five months?" "Five months. No new lesions. Smooth skin. Her dermatologist photographs the sites at every visit. Nothing new to document." I ordered it from my phone before I left the table. It arrived two days later. I applied it that evening. No expectations — three failed botanical oils and fourteen freeze sessions had taken care of those. Morning check. Patches still there. Too early. Week one — checking every morning. Still rough. Maybe the faintest change at the edge of one patch. I wasn't counting it. Week two — I ran my fingers across the back of my right hand. Smoother. Ran them again the next morning. Still smoother. The morning after. The same. Not noise. Something real. My daughter came over for dinner and watched me reach for something across the table without hesitating. "You didn't do that thing," she said. "What thing?" "Check your arms after. You just... reached." Week three — the patch on the back of my left hand. The one that had been raised and rough for four years. I pressed it flat with two fingers. It stayed flat. I pressed it again. Flat. I went outside and stood in the afternoon sun with my hands open. Fourteen freeze sessions never let me do that. I sat on the back step and just breathed. Week four — morning before my appointment with Dr. Whitfield. I ran my hands across both forearms. Smooth. Not the rough sandpaper I'd lived with for seven years. My daughter touched my arm when she stopped by and looked at me. At the appointment, the nurse did the initial examination. She looked at my hands and forearms. Stopped. Looked again. Photographed everything for the file. Dr. Whitfield came in. Opened my chart. His face changed. "The texture across your forearms — sites two, five, and eight — significantly reduced. The elevation at the patch margins — flat." "Yes." He looked at the previous visit photos. Rough, raised, spreading across both hands and forearms. Then the current images. Smooth. Flat. No new formations. "You completed the 5-fluorouracil course?" "No." He looked up. "No?" "I found a botanical oil that actually reaches the dermis. Cold-pressed camellia and sea buckthorn as the lipid carrier. Oil-soluble vitamin C at clinical concentration. Bakuchiol for cellular turnover. It penetrates all seven skin layers to the subclinical field. Where the freeze sessions and the diclofenac never got." His expression tightened. "Ms. Patterson, a cosmetic product doesn't constitute medical—" "My patches went from rough, raised, and actively spreading to smooth and flat in four weeks. No new lesions at sites that were generating every cycle. That's in my chart right now. Fourteen freeze sessions over seven years never gave me a single visit with nothing new on the watch list." He looked at the chart. Then at me. Then back. Silence. "What's the product?" "Dermiqua." He searched it. Read. Looked at the ingredient list. Camellia oil. Sea buckthorn. Oil-soluble vitamin C. Bakuchiol. Zero water. Another silence. "Continue with your current approach. I want to see you back in eight weeks. If the results are stable, we'll reconsider the monitoring protocol." If the results are stable, we'll reconsider the monitoring protocol. No field chemotherapy. No $2,720 today. No quarterly $1,000 cycles. No photodynamic treatment addressing the surface while the dermis kept generating. I walked out of the building. Sat in my car in the parking lot. Called my daughter. "Fifteen active sites. Seven years of spreading. Dr. Whitfield just cancelled the aggressive protocol." I heard her catch her breath. "Mom. I was watching you turn into Grandma." "I know." That was five months ago. My skin at this morning's check? Stable. Smooth. No new lesions. No rough patches returning. My dermatologist photographs the sites at every appointment. Nothing new to freeze. I'm wearing the clothes I stopped wearing. Reaching across tables. Standing in my garden in the afternoon sun without inventorying my arms afterward. I'm not following my mother's path. Last month my granddaughter was visiting. We were in the garden, walking the beds, talking about nothing in particular. She reached over and took my hand without thinking about it. Held it. Ran her thumb across the back of my hand at some point and said, "Nana, your hands are so smooth." I had to look away. Because seven years ago I started hiding these hands. And for the first time in all of that — smooth. --- If you're reading this, something in my story is yours. You've been on the freeze schedule. The patches keep coming back. Your dermatologist is talking about escalation — field chemotherapy, photodynamic therapy, more aggressive intervention — and you're sitting with a treatment plan that costs more and promises less than what you've already been through. Your mother or grandmother went through this. The quarterly appointments. The spreading that never stopped. The field therapy that came eventually. The life that slowly arranged itself around a condition that kept progressing anyway. You've done the math. $175 a session, four times a year, seven years. $4,900. For a field that keeps generating. You've tried the products people recommend. Diclofenac. Moisturizers. Maybe even other botanical oils. Nothing reached the field. Because nothing was formulated to reach the dermis. Here's what I want you to know: If I hadn't stopped at that table at the farmers market, I'd be two months into the 5-fluorouracil course right now. Six weeks of weeping skin. Then photodynamic sessions. Over $4,000 a year. New patches appearing at the edges of the treated zone because the dermal field is still running underneath. Following my mother's path. Nine years of freeze sessions, then field therapy, then more field therapy, then full recurrence, then none of her summers back. While the subclinical field — the actual source, the one that every freeze session addressed on the surface and never reached — kept generating underneath. But I found a third option. One that reaches the dermis. Not just clears the visible patches temporarily while the generating layer runs underneath. If you're where I was five months ago — exhausted from years of the quarterly schedule, watching your AK spread despite everything you've done — try Dermiqua. Morning and evening. Watch your skin. Give it a real trial. Your future self will thank you. --- I tried three botanical oils before Dermiqua. None of them worked because none of them reached the dermis. Here's why Dermiqua is different. 1. Cold-Pressed Camellia and Sea Buckthorn as the Carrier (Not Sunflower or Safflower) Most botanical body oils use sunflower or safflower as the carrier. They moisturize the surface. They don't penetrate to the dermis. Dermiqua uses cold-pressed camellia oil and sea buckthorn oil — the two lipid carriers that transport actives through all seven skin layers. To where the UV-damaged keratinocytes are generating new lesions. To the field. Freeze sessions clear what they can see. This reaches what they can't. 2. Oil-Soluble Vitamin C — Not the Water-Soluble Version Most vitamin C products use ascorbic acid — water-soluble. It sits on the stratum corneum. It doesn't reach the dermis where the field operates. Dermiqua uses ascorbyl tetraisopalmitate — oil-soluble vitamin C — at clinical concentration. Carried by the camellia and sea buckthorn into the dermal layer. Inhibiting the UV-induced oxidative cascade that drives abnormal keratinocyte proliferation. In the dermis. Where the field lives. Diclofenac softens the surface. This addresses the generating layer. 3. Bakuchiol at Clinical Concentration for Cellular Turnover Dermiqua includes bakuchiol at clinical concentration. Supports normal keratinocyte cycling without the irritation retinol causes in UV-damaged skin. Replacing abnormal proliferation with healthy cell renewal from the dermis outward. 4. Zero Water. Zero Filler. Full Penetration. Water dilutes penetration. Water-based compounds stay at the surface. Dermiqua has zero water. Zero filler. Sixteen cold-pressed botanicals. Every ingredient oil-soluble and lipid-delivered. Everything reaches the dermis. 5. 90-Day Money-Back Guarantee Try Dermiqua for up to 90 days. Watch your skin every morning. Run your fingers across the patches. Feel the texture change — or don't. If you don't see a meaningful difference — if the rough texture isn't smoothing, if the edges aren't flattening, if new lesions are still appearing on schedule — full refund. No questions asked. You've already spent enough watching sessions clear the visible patch and watching the next one form. --- You're being pressured. Your dermatologist wants aggressive field intervention. Field chemotherapy. Photodynamic therapy. Quarterly freeze sessions alongside. Thousands upfront, thousands every quarter. Maybe documentation threats. Maybe the sense that wanting to try something different is the same as accepting that your condition wins. You have two paths: One path: Start the aggressive protocol. Thousands today. Thousands every quarter. New lesions appearing at the treatment margins as the dermal field keeps generating. Another session scheduled. Repeat. Follow your mother's path. Another path: Do what I did. Find something that actually reaches the dermis where the field lives. Watch your skin every morning. Give it an honest 90-day trial with zero financial risk. I chose the second path. It saved me from the quarterly schedule. From $4,200 a year. From nine years of my mother's path compressed into my own arms. It gave me my hands back. --- Five months ago I was stuck. Fifteen active sites. Seven years of freeze sessions that never stopped the field. A new dermatologist with a $2,720 treatment plan and a documentation threat. I was watching myself become my mother. Nine years into her schedule, then field therapy, then more field therapy, then full recurrence, then no more summers the way she'd planned them. I sat at my kitchen table at 2:30 AM reading from women who had spent $5,000, $8,000, $12,000 on sessions and specialist visits. Patches still spreading. Still being told "come back in three months." I felt like there were only two options. Both of them losing. But there was a third. If you're where I was — done with the quarterly cycle, watching your AK spread despite everything you're doing — try Dermiqua. Watch your skin. Give it an honest 90-day trial. Your future self will thank you. 👉 dermiqua.com/pages/actinic-keratosis — Carol Patterson, 61, Portland OR P.S. — Smoother texture by week two. Flat patches by week three. Brought the results to Dr. Whitfield at week four. He cancelled the aggressive protocol on the spot. Fourteen freeze sessions never gave me a single visit with nothing new on the watch list. Not once. Your dermatologist might back off too — if you have results to show them. P.P.S. — Every freeze session clears the patch they can see while the field underneath generates the next one. The field doesn't respond to liquid nitrogen on the surface. It lives in the dermis. Only lipid-delivered oil-soluble actives reach it. Don't spend another year on the quarterly schedule. Order now. P.P.P.S. — My granddaughter ran her thumb across the back of my hand last month and said "Nana, your hands are so smooth." Seven years of freeze sessions and thousands of dollars never let her say that. A bottle of Dermiqua did.